Gastroenterology Practice Questions

Q: What is the first-line treatment for a severe exacerbation of ulcerative colitis?

Corticosteroids. ### Explanation The management of Ulcerative Colitis (UC) is stratified based on the severity of the disease (Truelove and Witts criteria). For a **severe exacerbation**, the primary goal is to induce rapid remission and prevent complications like toxic megacolon. **1. Why Corticosteroids are the Correct Answer:** Systemic corticosteroids (e.g., IV Hydrocortisone or Methylprednisolone) are the **gold standard first-line therapy** for inducing remission in severe UC [1]. They possess potent anti-inflammatory properties that act rapidly to reduce mucosal inflammation. According to clinical guidelines, if a patient does not respond to IV steroids within 3–5 days, they are considered "steroid-refractory," and rescue therapy is initiated. **2. Analysis of Incorrect Options:** * **A. Sulfasalazine:** This is a 5-ASA compound used primarily for **maintenance** of remission or for treating **mild-to-moderate** active disease [1]. It is insufficient for severe exacerbations. * **C. Infliximab:** This is an anti-TNF agent used as **"rescue therapy"** if the patient fails to respond to initial IV corticosteroids. It is not the first-line choice. * **D. Cyclosporine:** Similar to Infliximab, this calcineurin inhibitor is reserved for **steroid-refractory** severe UC as a bridge to long-term maintenance therapy. **3. High-Yield Clinical Pearls for NEET-PG:** * **Truelove and Witts Criteria for Severe UC:** >6 bloody stools/day + systemic toxicity (Fever >37.8°C, Tachycardia >90 bpm, Anemia 30 mm/hr). * **Drug of Choice for Maintenance:** Mesalamine (5-ASA) is preferred over Sulfasalazine due to fewer side effects [1]. * **Toxic Megacolon:** A dreaded complication of severe UC; diagnosed when colonic dilatation is **>6 cm** on X-ray. * **Surgery:** Total proctocolectomy with Ileal Pouch-Anal Anastomosis (IPAA) is the curative surgical procedure of choice.

Q: What is the cause of pruritus in primary biliary cirrhosis?

Transient receptor potential vanilloid 1 (TRPV1). Pruritus is a common and distressing symptom of **Primary Biliary Cholangitis (PBC)**, formerly known as Primary Biliary Cirrhosis [1]. The pathophysiology involves the accumulation of cholestatic pruritogens (such as bile acids and lysophosphatidic acid) that activate specific neural pathways [2]. **Why TRPV1 is correct:** Recent research has identified **Transient Receptor Potential Vanilloid 1 (TRPV1)**, a non-selective cation channel found on sensory neurons, as a key mediator in cholestatic itch [2]. Pruritogens like **Lysophosphatidic Acid (LPA)**, formed by the enzyme autotaxin, activate these TRPV1 channels on peripheral nerve endings, leading to the transmission of the itch sensation to the central nervous system. **Analysis of Incorrect Options:** * **A. TLR4:** This is a pattern recognition receptor involved in innate immunity and the inflammatory response to LPS (endotoxin), not the primary mediator of pruritus. * **B. GLP-1:** This is an incretin hormone involved in glucose homeostasis and insulin secretion. * **D. GRP:** While Gastrin-releasing peptide is a known neurotransmitter in the spinal cord's "itch circuit," the specific peripheral trigger mechanism highlighted in recent PBC studies emphasizes the role of the TRPV1 channel. **High-Yield Clinical Pearls for NEET-PG:** * **First-line treatment for PBC pruritus:** Cholestyramine (bile acid sequestrant). * **Second-line/Alternative treatments:** Rifampicin (induces P450 to metabolize pruritogens), Naltrexone (opioid antagonist), and Sertraline (SSRI). * **Diagnostic Marker:** Anti-Mitochondrial Antibody (AMA) is positive in >95% of cases [3]. * **Key Enzyme:** **Autotaxin** levels correlate with the severity of cholestatic itch.

Q: What is the best diagnostic test for esophageal motility disorders?

Manometry. **Explanation:** **Esophageal Manometry** is the **gold standard** and best diagnostic test for evaluating esophageal motility disorders (e.g., Achalasia cardia, Diffuse Esophageal Spasm, Nutcracker esophagus) [1]. It directly measures the pressure, timing, and coordination of the Lower Esophageal Sphincter (LES) and the esophageal body during swallowing. High-resolution manometry (HRM) is the modern iteration, providing a "topographic map" (Chicago Classification) to precisely categorize these disorders [1]. **Analysis of Incorrect Options:** * **Barium studies:** While often the initial screening test (showing the "bird’s beak" appearance in Achalasia or "corkscrew" esophagus in DES), it is a structural/radiological study and cannot definitively quantify pressure or motor function [1]. * **Esophagoscopy:** Primarily used to rule out mechanical obstructions or "pseudoachalasia" (malignancy at the GE junction) [1]. It cannot diagnose motility issues as the esophagus often appears normal or merely dilated. * **24-hour pH monitoring:** This is the gold standard for diagnosing **Gastroesophageal Reflux Disease (GERD)**, not motility disorders. It measures acid exposure time but does not assess peristalsis. **High-Yield Clinical Pearls for NEET-PG:** * **Achalasia Cardia:** Characterized on manometry by **incomplete LES relaxation** (Integrated Relaxation Pressure >15 mmHg) and **aperistalsis** in the distal esophagus [1]. * **Nutcracker Esophagus:** Characterized by high-amplitude peristaltic contractions (>180 mmHg) [1]. * **Initial vs. Best:** For dysphagia, the initial test is often Barium Swallow or Endoscopy, but the **most definitive/best** test for motility is always Manometry [1].

Q: What is the major risk factor, along with alcohol intake, for the development of alcoholic liver disease?

Chronic HCV infection. The development and progression of alcoholic liver disease (ALD) are influenced by several cofactors, with **Chronic Hepatitis C Virus (HCV) infection** being the most significant. **1. Why Chronic HCV is the correct answer:** There is a synergistic relationship between alcohol consumption and HCV [1]. Alcohol enhances HCV replication and increases oxidative stress within hepatocytes [1]. Clinical studies consistently show that patients with both chronic HCV and heavy alcohol intake develop cirrhosis at a younger age, have a higher frequency of decompensation, and face a significantly increased risk of developing **Hepatocellular Carcinoma (HCC)** compared to those with either risk factor alone. **2. Why other options are incorrect:** * **Chronic HBV infection:** While HBV is a major cause of cirrhosis and HCC, its synergistic link with alcohol is less pronounced and less frequently documented in epidemiological studies compared to the alcohol-HCV interaction. * **Non-hepatotropic virus infection:** Viruses like CMV or EBV may cause transient hepatitis but do not lead to chronic liver disease or synergize with alcohol to promote cirrhosis. * **Abdominal tuberculosis:** This is an infectious granulomatous disease primarily affecting the peritoneum and bowel [2]. It does not directly accelerate the pathophysiological mechanisms of alcoholic steatohepatitis or fibrosis. **High-Yield Clinical Pearls for NEET-PG:** * **Gender:** Women are more susceptible to ALD than men at lower levels of alcohol intake due to lower levels of gastric alcohol dehydrogenase [1]. * **Obesity:** Non-alcoholic fatty liver disease (NAFLD) and alcohol have a "double hit" effect on liver fibrosis. * **Genetic Factor:** Polymorphisms in the **PNPLA3 gene** are strongly associated with an increased risk of alcoholic cirrhosis. * **Threshold:** The risk of cirrhosis increases significantly with the consumption of >30g of ethanol per day [1].

Q: Which of the following is NOT a complication of ulcerative colitis?

Peptic ulceration. **Explanation:** Ulcerative Colitis (UC) is a chronic inflammatory bowel disease characterized by mucosal inflammation limited to the colon and rectum [2]. Complications are categorized into intestinal (local) and extra-intestinal (systemic) manifestations [3]. **Why Peptic Ulceration is the correct answer:** Peptic ulceration is a disease of the upper gastrointestinal tract (stomach and duodenum) primarily caused by *H. pylori* infection or NSAID use [1]. It is **not** pathophysiologically linked to ulcerative colitis. While Crohn’s disease can involve any part of the GIT from mouth to anus (including the stomach), UC strictly involves the large intestine [2]. **Analysis of incorrect options:** * **Arthritis:** This is the **most common** extra-intestinal manifestation of UC. It typically presents as peripheral arthritis (often mirroring bowel activity) or axial involvement like Ankylosing Spondylitis (independent of bowel activity) [3]. * **Sclerosing Cholangitis (PSC):** Primary Sclerosing Cholangitis is a classic hepatobiliary complication [3]. Approximately 70-80% of patients with PSC have underlying UC. It increases the risk of cholangiocarcinoma. * **Toxic Megacolon:** A life-threatening intestinal complication where the colon dilates (>6 cm) due to transmural inflammation, leading to a risk of perforation and sepsis. **NEET-PG High-Yield Pearls:** * **Most common extra-intestinal manifestation:** Peripheral Arthritis [3]. * **Most specific skin manifestation:** Pyoderma Gangrenosum (more common in UC than Crohn's). * **Malignancy risk:** UC significantly increases the risk of Colorectal Carcinoma; screening colonoscopy is recommended 8–10 years after diagnosis. * **Serology:** p-ANCA is positive in 60-70% of UC patients.

Question 1

What is the first-line treatment for a severe exacerbation of ulcerative colitis?

Accepted Answer

Corticosteroids

Answer

Sulfasalazine

Answer

Infliximab

Answer

Cyclosporine

Question 2

What is true about ulcerative colitis?

Accepted Answer

Involves the rectum and then extends proximally throughout the colon.

Answer

Involves only the colon.

Answer

Skip lesions are seen.

Answer

The ileum is not involved.

Question 3

In patients who have undergone appendicectomy, which of the following conditions is less likely to develop?

Accepted Answer

Ulcerative colitis

Answer

Crohn's disease

Answer

Both

Answer

None

Question 4

What is the cause of pruritus in primary biliary cirrhosis?

Accepted Answer

Transient receptor potential vanilloid 1 (TRPV1)

Answer

Toll-like receptor 4 (TLR4)

Answer

Glucagon-like peptide 1 (GLP-1)

Answer

Gastrin-releasing peptide (GRP)

Question 5

Colonic pseudo obstruction occurs in all, EXCEPT:

Accepted Answer

Hyperthyroidism

Answer

Diabetes mellitus

Answer

Dermatomyositis

Answer

Scleroderma

Question 6

What is the treatment for diffuse esophageal spasm?

Accepted Answer

Nitrates

Answer

Pneumatic dilatation

Answer

Oxybutynin

Answer

Botulinum toxin and pneumatic dilation

Question 7

What is the best diagnostic test for esophageal motility disorders?

Accepted Answer

Manometry

Answer

Barium studies

Answer

Esophagoscopy

Answer

24-hour pH monitoring

Question 8

All are features of bile acid diarrhea, EXCEPT:

Accepted Answer

Reduced bile acid pool

Answer

Extensive ileal involvement is seen

Answer

Hepatic synthesis compensates fecal loss

Answer

Good response to cholestyramine

Question 9

What is the major risk factor, along with alcohol intake, for the development of alcoholic liver disease?

Accepted Answer

Chronic HCV infection

Answer

Chronic HBV infection

Answer

Non hepatotropic virus infection

Answer

Abdominal tuberculosis

Question 10

Which of the following is NOT a complication of ulcerative colitis?

Accepted Answer

Peptic ulceration

Answer

Arthritis

Answer

Sclerosing cholangitis

Answer

Toxic megacolon

Gastroenterology — MCQs

Gastroenterology — MCQs

On this page

Practice by Chapter

Want unlimited practice?